Phagenesis
The company develops the Phagenyx System, a medical device that uses pharyngeal electrical stimulation (PES) to treat neurogenic dysphagia, specifically in post-stroke patients. The system applies electrical stimulation to sensory nerves to restore the brain's ability to initiate and coordinate safe swallowing. It is designed for early bedside intervention in hospital and ICU settings to reduce clinical complications like pneumonia and shorten hospital stays.
Healthtech
Medical Devices
Healthcare
Funding summary
- Total raised
- €63.8M
- Funding rounds
- 4
Investors in Phagenesis
Investors on record for Phagenesis. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Phagenesis?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors